Stock Research: OPKO Health

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

OPKO Health

NSQ:OPK US68375N1037
24
  • Value
    59
  • Growth
    9
  • Safety
    Safety
    72
  • Combined
    31
  • Sentiment
    13
  • 360° View
    360° View
    24
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. It operates in pharmaceutical and diagnostics industries, with key pharmaceutical products like Somatrogon (NGENLA) and Rayaldee, and clinical laboratory operations through BioReference. Its pharmaceutical operations are in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, and the United States. In the last fiscal year, the company had a market cap of $1071 millions, profits of $219 millions, revenue of $713 millions, and 2997 employees.

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
59 41 44 18
Growth
9 57 67 1
Safety
Safety
72 86 49 61
Sentiment
13 49 42 13
360° View
360° View
24 77 38 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
50 95 95 95
Opinions Change
50 50 50 50
Pro Holdings
n/a 51 44 3
Market Pulse
4 10 7 4
Sentiment
13 49 42 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
59 41 44 18
Growth
9 57 67 1
Safety Safety
72 86 49 61
Combined
31 82 10 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
41 23 31 25
Price vs. Earnings (P/E)
1 1 1 1
Price vs. Book (P/B)
88 84 85 79
Dividend Yield
1 1 1 1
Value
59 41 44 18
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
8 10 6 1
Profit Growth
8 76 80 38
Capital Growth
42 28 75 4
Stock Returns
37 93 85 63
Growth
9 57 67 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
64 85 82 80
Refinancing
84 94 43 45
Liquidity
18 9 15 40
Safety Safety
72 86 49 61

Similar Stocks

Discover high‑ranked alternatives to OPKO Health and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: